Literature DB >> 8083651

Tumor necrosis factor, interleukin-2, and interferon-gamma in adult varicella.

M R Wallace1, I Woelfl, W A Bowler, P E Olson, N B Murray, S K Brodine, E C Oldfield, A M Arvin.   

Abstract

Adult varicella can be a severe illness complicated by pneumonia, encephalitis, or prolonged fever. This study measured levels of tumor necrosis factor (TNF)-alpha, interleukin-2 (IL-2), and interferon gamma (IFN-G) in a consecutive group of 31 adult varicella patients presenting within 24 hours of rash onset. All cytokines were assayed using an ELISA technique. TNF-alpha was detectable in 71% of patients with a mean level of 52 pg/ml. IL-2 was detectable in 29% with a mean level of 1040 pg/ml. IFN-gamma was detectable in only 9%. There was no correlation between TNF, IL-2, or IFN-G level and clinical severity as determined by duration and severity of cutaneous findings, duration of fever, frequency of hepatitis, or thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083651     DOI: 10.1002/jmv.1890430113

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

Review 1.  Herpes zoster and the search for an effective vaccine.

Authors:  N Arnold; I Messaoudi
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

2.  Modulation of major histocompatibility class II protein expression by varicella-zoster virus.

Authors:  A Abendroth; B Slobedman; E Lee; E Mellins; M Wallace; A M Arvin
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Local immune responses and systemic cytokine responses in zoster: relationship to the development of postherpetic neuralgia.

Authors:  M Zak-Prelich; R C McKenzie; A Sysa-Jedrzejowska; M Norval
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

4.  Varicella zoster virus productively infects human natural killer cells and manipulates phenotype.

Authors:  Tessa Mollie Campbell; Brian Patrick McSharry; Megan Steain; Thomas Myles Ashhurst; Barry Slobedman; Allison Abendroth
Journal:  PLoS Pathog       Date:  2018-04-30       Impact factor: 6.823

Review 5.  Innate antiviral defenses in body fluids and tissues.

Authors:  S Baron; I Singh; A Chopra; D Coppenhaver; J Pan
Journal:  Antiviral Res       Date:  2000-11       Impact factor: 5.970

Review 6.  Innate defences against viraemia.

Authors:  I P Singh; S Baron
Journal:  Rev Med Virol       Date:  2000 Nov-Dec       Impact factor: 6.989

Review 7.  Manipulation of the Innate Immune Response by Varicella Zoster Virus.

Authors:  Chelsea Gerada; Tessa M Campbell; Jarrod J Kennedy; Brian P McSharry; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  Front Immunol       Date:  2020-01-24       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.